Red blood cells promote survival and cell cycle progression of human peripheral blood T cells independently of CD58/LFA-3 and heme compounds

Cellular Immunology

Volumn 224, Issue 1, 2003, Pages 17-28

  Fonseca, Ana Mafalda ^a,b   Pereira, Carlos Filipe ^a   Porto, Graça ^a,b,c   Arosa, Fernando A ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c HOSPITAL DE SANTO ANTÓNIO   (Portugal)

Author keywords

Apoptosis; CD58 LFA 3; CD8+; Cell cycle; Heme; Red blood cell; Survival; T cell

Indexed keywords

CD2 ANTIGEN; CD3 ANTIGEN; CD8 ANTIGEN; HEME; HEME DERIVATIVE; HEMOGLOBIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; PROTOPORPHYRIN;

ANTIGEN FUNCTION; APOPTOSIS; ARTICLE; CELL CYCLE; CELL DEATH; CELL DIVISION; CELL SURVIVAL; CIRCULATION; CONTROLLED STUDY; ERYTHROCYTE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE CULTURE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; PARAMETER; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PURIFICATION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0142169441     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-8749(03)00170-9     Document Type: Article

References (72)

1. Garboczi D.N., Biddison W.E. Shapes of MHC restriction. Immunity. 10:1999;1-7.
2. Freitas A.A., Rocha B. Peripheral T cell survival. Curr. Opin. Immunol. 11:1999;152-156.
3. Sprent J. Burnet oration, T-cell survival and the role of cytokines. Immunol. Cell Biol. 79:2001;199-206.
4. Sansom D.M. CD28, CTLA-4 and their ligands: who does what and to whom? Immunology. 101:2000;169-177.
5. Scaffidi C., Kirchhoff S., Kramer P.H., Peter M.E. Apoptosis signaling in lymphocytes. Curr. Opin. Immunol. 11:1989;277-285.
6. Freitas A.A., Rocha B. Population biology of lymphocytes: the flight for survival. Ann. Rev. Immunol. 18:2000;83-111.
7. Hall M.A., Norman P.J., Thiel B., Tiwari H., Peiffer A., Vaughan R.W., Prescott S., Leppert M., Schork N.J., Lanchbury J.S. Quantitative trait loci on chromosomes 1, 2, 3, 4, 8, 9, 11, 12, and 18 control variation in levels of T and B lymphocyte subpopulations. Am. J. Hum. Gen. 70:2002;1172-1182.
8. Julius M., Maroun C.R., Haughn L. Distinct roles for CD4 and CD8 as co-receptors in antigen receptor signaling. Immunol. Today. 14:1993;177-182.
9. Parra E., Wingren A.G., Hedlund G., Kalland T., Dohlsten M. The role of B7-1 and LFA-3 in costimulation of CD8 T cells. J. Immunol. 158:1997;637-642.
10. Ferreira C., Barthlott T., Garcia S., Zamoyska R., Stockinger B. Differential survival of naïve CD4 and CD8 T cells. J. Immunol. 165:2000;3689-3694.
11. Dengler T.J., Pober J.S. Human vascular endothelial cells stimulate memory but not naive CD8+ T cells to differentiate into CTL retaining an early activation phenotype. J. Immunol. 164:2000;5146-5155.
12. Bertolino P., Bowen D., McCaughan G.W., Fazekas de St. Groth B. Antigen-specific primary activation of CD8+ T cells within the liver. J. Immunol. 166:2001;5430-5438.
13. Krensky A.M., Sanchez-Madrid F., Robbins E., Nagy T.A., Springer T., Burakoff S.J. The functional significance, distribution, and structure of LFA-1, LFA-2, and LFA-3: cell surface antigens associated with CTL-target interactions. J. Immunol. 131:1983;611-616.
14. Le Guiner S., Le Drean E., Labarriere N., Fonteneau J.F., Viret C., Diez E. LFA-3 co-stimulates cytokine secretion by cytotoxic T lymphocytes by providing a TCR-independent activation signal. Eur. J. Immunol. 28:1998;1322-1331.
15. Wesch D., Marx S., Kabelitz D. Monocyte-dependent death of freshly isolated T lymphocytes: induction by phorbolester and mitogens and differential effects of catalase. J. Immunol. 161:1998;1248-1256.
16. Roberts A.I., Lee L., Schwarz E., Groh V., Spies T., Ebert E.C., Jabri B. NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment. J. Immunol. 167:2001;5527-5530.
17. Ku C.C., Kappler J., Marrack P. The growth of the very large CD8+ T cell clones in older mice is controlled by cytokines. J. Immunol. 166:2001;2186-2193.
18. Wong P., Pamer E.G. Cutting edge: antigen-independent CD8 T cell proliferation. J. Immunol. 166:2001;5864-5868.
19. Tough D.F., Zhang X., Sprent J. An IFN-gamma-dependent pathway controls stimulation of memory phenotype CD8+ T cell turnover in vivo by IL-12, IL-18, and IFN-gamma. J. Immunol. 166:2001;6007-6011.
20. Kieper W.C., Prlic M., Schmidt C.S., Mescher M.F., Jameson C.S. IL-12 enhances CD8 T cell homeostatic expansion. J. Immunol. 66:2001;5515-5521.
21. Rowbottom A.W., Lepper M.A., Garland R.J., Cox C.V., Corley E.G. Interleukin-10-induced CD8 cell proliferation. Immunology. 98:1999;80-89.
22. Walsh P.T., O'Connor R. The insulin-like growth factor-I receptor is regulated by CD28 and protects activated T cells from apoptosis. Eur. J. Immunol. 30:2000;1010-1018.
23. Tu W., Cheung P.T., Lau Y.L. Insulin-like growth factor 1 promotes cord blood T cell maturation and inhibits it spontaneous and phytohemagglutinin- induced apoptosis through different mechanisms. J. Immunol. 165:2000;1331-1336.
24. Delgado M., Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit antigen-induced apoptosis of mature T lymphocytes by inhibiting Fas ligand expression. J. Immunol. 164:2000;1200-1210.
25. Westermann J., Bode U. Distribution of activated T cells migrating through the body: a matter of life and death. Immunol. Today. 20:1999;302-306.
26. Tarnvik A. Lymphocyte stimulation by a complex of phytohaemagglutinin and red cell membrane. Acta Path. Microbiol. Scand. (Sect. B). 79:1971;588-594.
27. Johnson R.A., Smith T., Kirkpatrick C. Augmentation of phytohemagglutinin mitogenic activity by erythrocyte membranes. Cell. Immunol. 3:1972;186-197.
28. Virella G., Rugeles M.T., Hyman B., La Via M., Goust J.M., Frankis M., Bierer B.E. The interaction of CD2 with its LFA-3 ligand expressed by autologous erythrocytes results in enhancement of B cell responses. Cell. Immunol. 116:1988;308-319.
29. Kalechman Y., Herman S., Gafter U., Sredni B. Enhancing effects of autologous erythrocytes on human or mouse cytokine secretion and IL-2R expression. Cell. Immunol. 148:1983;114-129.
30. Shau H., Gupta R.K., Golub S.H. Identification of a natural killer enhancing factor (NKEF) from human erythroid cells. Cell. Immunol. 147:1993;1-11.
31. Ebert E. Sheep red blood cells enhance T-lymphocyte proliferation. Clin. Immunol. Immunopathol. 37:1985;203-212.
32. Silva A., Lopez-Botet M., Alvarez J., Landazuri M.O. Enhancement of the functional activities of human T cells after their interaction with SRBC. J. Immunol. 126:1981;393-397.
33. Jyonouchi H., Kincade P.W., Misra H.P. Analysis of the effects of erythrocytes on mitogen-dependent clonal proliferation of murine B lymphocytes. Cell. Immunol. 83:1984;189-198.
34. Sigfusson A., Souhami R. The effects of erythrocyte contamination on pokeweed mitogen induced immunoglobulin synthesis in man. J. Immunol. Methods. 72:1984;167-170.
35. Gafter U., Kalechman Y., Orlin J.B., Levi J., Sdreni B. Anemia of uremia is associated with reduced in vitro cytokine secretion: immunopotentiating activity of red blood cells. Kidney Int. 45:1994;224-231.
36. Porto B., Fonseca A.M., Godinho I., Arosa F.A., Porto G. Human red blood cells have an enhancing effect on the relative expansion of CD8+ T lymphocytes in vitro. Cell. Prolif. 34:2001;359-367.
37. Selvaraj P., Dustin M.L. Rosetting of human T lymphocytes with sheep and human erythrocytes. Comparison of human and sheep ligand binding using purified E receptor. J. Immunol. 138:1987;2690-2695.
38. Plunkett M.L., Sanders M.E., Selvaraj P., Dustin M.L., Springer T.A. Rosetting of activated human T lymphocytes with autologous erythrocytes, Definition of the receptor and ligand molecules as CD2 and lymphocyte function-associated antigen 3 (LFA-3). J. Exp. Med. 165:1987;664-676.
39. Dustin M.L., Sanders M.E., Shaw S., Springer T.A. Purified lymphocyte function-associated antigen 3 binds to CD2 and mediates T-lymphocyte adhesion. J. Exp. Med. 165:1987;677-692.
40. Fonseca A.M., Porto G., Uchida K., Arosa F.A. Red blood cells inhibit activation-induced cell death and oxidative stress in human peripheral blood T lymphocytes. Blood. 97:2001;3152-3160.
41. Dustin M.L., Selvaraj P., Mattaliano R.J., Springer T.A. Anchoring mechanisms for LFA-3 cell adhesion glycoprotein at membrane surface. Nature. 329:1987;846-848.
42. Lyons A.B., Parish C.R. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods. 171:1994;131-137.
43. Springer T.A., Dustin M.L., Kishimoto T.K., Marlin S.D. The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system. Annu. Rev. Immunol. 5:1987;223-252.
44. Tartter P.I. Immunologic effects of blood transfusion. Immunol. Invest. 24:1995;277-288.
45. Claas F.H.J., Roelen D.L., van Rood J.J., Brand A. Modulation of the alloimmune response by blood transfusions. Transfus. Clin. Biol. 8:2001;315-317.
46. Stahl D., Lacroix-Desmazes S., Sibrowski W., Kazatchkine M.D., Kaveri S.V. Broad alterations of self-reactive antibody-repertoires of plasma IgM and IgG in B-cell chronic lymphocytic leukemia (B-CLL) and B-CLL related target-restricted autoimmunity. Leuk. Lymphoma. 42:2001;163-176.
47. Stahl D., Lacroix-Desmazes S., Sibrowski W., Kazatchkine M.D., Kaveri S.V. Red blood cell transfusions are associated with alterations in self-reactive antibody repertoires of plasma IgM and IgG, independent of the presence of a specific immune response toward RBC antigens. Clin. Immunol. 105:2002;25-35.
48. Song S., Goodwin J., Zhang J., Babbitt B., Lathey J.L. Effect of contaminating red blood cells on OKT3-mediated polyclonal activation of peripheral blood mononuclear cells. Clin. Diagn. Lab. Immunol. 9:2002;708-712.
49. Matutes E. T-cell prolymphocytic leukemia. Cancer Control. 5:1998;19-24.
50. Rabinowitz R., Hadar R., Schlesinger M. The appearance of the CD4+CD8+ phenotype on activated T cells: possible role of antigen transfer. Hum. Immunol. 55:1997;1-10.
51. Arosa F.A., Irwin C., Mayer L., de Sousa M., Posnett D.N. Interactions between peripheral blood CD8 T lymphocytes and intestinal epithelial cells (iEC). Clin. Exp. Immunol. 112:1998;226-236.
52. Hershberg R.M., Mayer L.F. Antigen processing and presentation by intestinal epithelial cells - polarity and complexity. Immunol. Today. 21:2000;123-128.
53. Groh V., Rhinehart R., Randolph-Habecker J., Topp M.S., Riddell S.R., Spies T. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immunol. 2:2001;255-260.
54. Chen T., Goldstein J.S., O'Boyle K., Whitman M.C., Brunswick M., Kozlowski S. ICAM-1 co-stimulation has differential effects on the activation of CD4+ and CD8+ T cells. Eur. J. Immunol. 29:1999;809-814.
55. Bernard A., Tran H.C., Boumsell L. Three different erythrocyte surface molecules are required for spontaneous T cell rosette formation. J. Immunol. 139:1987;18-23.
56. Bernard A., Aubrit F., Raynal B., Pham D., Boumsell L. A T cell surface molecule different from CD2 is involved in spontaneous rosette formation with erythrocytes. J. Immunol. 140:1988;1802-1807.
57. Hale L.P., Singer K.H., Haynes B.F. CD44 antibody against In(Lu)-related p80, lymphocyte-homing receptor molecule inhibits the binding of human erythrocytes to T cells. J. Immunol. 143:1989;3944-3948.
58. Telen M.J. Red blood cell surface adhesion molecules: their possible roles in normal human physiology and disease. Semin. Hematol. 37:2000;130-142.
59. Groux H., Huet S., Aubrit F., Tran H.C., Boumsell L., Bernard A. A 19-kDa human erythrocyte molecule H19 is involved in rosettes, present on nucleated cells, and required for T cell activation. Comparison of the roles of H19 and LFA-3 molecules in T cell activation. J. Immunol. 142:1989;3013-3020.
60. Deckert M., Kubar J., Zoccola D., Bernard-Pomier G., Angelisova P., Horejsi V., Bernard A. CD59 molecule: a second ligand for CD2 in T cell adhesion. Eur. J. Immunol. 22:1992;2943-2947.
61. Novogrodsky A., Suthanthiran M., Stenzel K.H. Immune stimulatory properties of metalloporphyrins. J. Immunol. 143:1989;3981-3987.
62. Novogrodsky A., Suthanthiran M., Stenzel K.H. Ferro-mitogens: iron-containing compounds with lymphocyte-stimulatory properties. Cell Immunol. 133:1991;295-305.
63. Costa L.M.G., Moura E.M.F., Moura J.J.G., de Sousa M. Iron compounds after erythrophagocytosis. Biochem. Biophys. Res. Commun. 247:1998;159-165.
64. Stepien H., Kunert-Radek J., Stanisz A., Zerek-Melen G., Pawlikowski M. Inhibitory effect of porphyrins on the proliferation of mouse spleen lymphocytes in vitro. Biochem. Biophys. Res. Commun. 174:1991;313-322.
65. Marchetti P., Hirsch T., Zamzami N., Castedo M., Decaudin D., Susin S.A., Masse B., Kroemer G. Mitochondrial permeability transition triggers lymphocyte apoptosis. J. Immunol. 157:1996;4830-4836.
66. Galan P., Davila M., Mekki N., Herchberg S. Iron deficiency, inflammatory processes and humoral immunity in children. Int. J. Vitam. Nutr. Res. 58:1988;25-30.
67. Kuvibidila S., Daedenne M., Savino W., Lepault F. Influence of iron-deficiency anemia on selected thymus functions in mice: thymulin biological activity, T-cell subsets, and thymocyte proliferation. Am. J. Clin. Nutr. 51:1990;228-232.
68. Jason J., Archibald L.K., Nwanyanwu O.C., Bell M., Jensen R.J., Gunter E., Buchanan J., Kazembe P.N., Dobbie H., Jarvis W.R. The effects of iron deficiency on lymphocyte cytokine production and activation: preservation of hepatic iron but not at all cost. Clin. Exp. Immunol. 126:2001;466-473.
69. Naughton B.A., Dornfest B.S., Bush M.E., Carlson C.A., Lapin D.M. Immune activation is associated with phenylhydrazine-induced anemia in the rat. J. Lab. Clin. Med. 115:1990;498-507.
70. Gafter U., Kalechman Y., Sredni B. Induction of a subpopulation of suppressor cells by a single blood transfusion. Kidney Int. 41:1992;143-148.
71. Prince H.E. The significance of T lymphocytes in transfusion medicine. Transfus. Med. Rev. 6:1992;32-43.
72. F.A. Arosa, C.F. Pereira, A.M. Fonseca, Red blood cells as modulators of T cell growth and survival, Curr. Pharm. Des. (in press).